- Login
 - Register
 - Home/Current Issue
 - About the journal
 - Editorial board
 - Online submission
 - Instructions for authors
 - Subscriptions
 - Foundation Acta Endocrinologica
 - Archive
 - Contact
 
            Romanian Academy
            
            The Publishing House of the Romanian Academy
            
        ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
        This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
    
    Ozcabi B, Kirmizibekmez H, Yesiltepe Mutlu G, Dursun F, Guran T
    
    
    Management of Rapidly Progressive Precocious Puberty in a Patient with Mosaic Turner Syndrome
    
    
    Acta Endo (Buc) 2021, 17 (1): 101-105doi: 10.4183/aeb.2021.101
    
    
    Context. Rapidly progressive precocious puberty
(RPPP) is a rare condition in Turner syndrome (TS), with no
consensus on treatment and follow-up. Only 12 cases have
been reported so far.
Objective. We aimed to evaluate the effects of
the GnRH analog (GnRHa) on growth and anti-mullerian
hormone (AMH) levels in TS and RPPP.
Design. The clinical and laboratory data was
recorded at baseline and after treatment.
Subjects and methods. An 8.1-year old girl with a
karyotype of 45, X/46, XX presented with breast development
at Tanner stage-2. Breast development advanced to Tanner
stage-3 at the age of 8.7 years. Growth velocity (GV) was 8
cm/year. Bone age was 11 years with a predicted adult height
of 152 cm. Luteinizing hormone (LH) was 1.69mIU/mL
and estradiol was 33pg/mL, confirming the central puberty.
AMH level was 6.33ng/mL. The sizes of ovaries and uterus
were compatible with the pubertal stage, with an endometrial
thickness of 5 mm. GnRHa was started for RPPP.
Results. After three months, GV declined to 0 cm/3
months and AMH level to 50% of the baseline. Growth
hormone (GH) treatment was started for insufficient growth.
GV improved with GH treatment, as well as a far more
decreased AMH level.
Conclusion. GV usually declines before puberty
in patients with TS, even if the mid-parental height is tall.
RPPP should be considered if GV is increased. Excessive
suppression of growth may be prevented with GH treatment.
GnRHa treatment also plays a role in reducing AMH levels
in patients with TS.
    
    
    Keywords: GnRH analog, Rapidly progressive
precocious puberty, Turner syndrome.
    
    
    Correspondence: Bahar Ozcabi, Istanbul Yeni Yuzyil University School of Medicine Gaziosmanpasa Hospital, Department of Pediatrics,
Division of Pediatric Endocrinology, Çukurçesme Cd. 5 Posta kodu: 34245 Gaziosmanpasa, Istanbul, Turkey, E-mail: taskinbahar79@yahoo.com